Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results

Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with... Int J Colorectal Dis (2017) 32:1295–1301 DOI 10.1007/s00384-017-2861-1 ORIGINAL ARTICLE Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results 1,2 1 1 3 4 Susanne Merkel & Klaus Weber & Jonas Göhl & Abbas Agaimy & Rainer Fietkau & 1 1 1 Werner Hohenberger & Robert Grützmann & Paul Hermanek Accepted: 7 July 2017 /Published online: 20 July 2017 Springer-Verlag GmbH Germany 2017 Abstract y0 and highest in UICC stage yIV. The 3-year DFS-rate was Purpose Survival is an important indicator of outcome quality always lower (worse) than the 5-year OS rate and higher in rectal carcinoma. The 5-year survival rate is the typical (better) than the 7-year OS rate, with the exception of stage outcome measurement. In patients with neoadjuvant chemo- yIV. radiation followed by curative surgery, 7 years of follow-up is Conclusions Comparisons of survival are only meaningful if recommended. Different methods of survival analysis lead to the same methods are applied. The 3-year rate of DFS was different results. Here, we compared four different methods. always worse than the rate of 5-year OS. Therefore, the 3-year Methods The data of 439 patients with rectal carcinoma treat- rate of DFS appears to be http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Colorectal Disease Springer Journals

Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results

Loading next page...
 
/lp/springer_journal/survival-analysis-in-rectal-carcinoma-after-neoadjuvant-chemoradiation-TS0upX0Zxj
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Surgery; Internal Medicine; Gastroenterology; Hepatology; Proctology
ISSN
0179-1958
eISSN
1432-1262
D.O.I.
10.1007/s00384-017-2861-1
Publisher site
See Article on Publisher Site

Abstract

Int J Colorectal Dis (2017) 32:1295–1301 DOI 10.1007/s00384-017-2861-1 ORIGINAL ARTICLE Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results 1,2 1 1 3 4 Susanne Merkel & Klaus Weber & Jonas Göhl & Abbas Agaimy & Rainer Fietkau & 1 1 1 Werner Hohenberger & Robert Grützmann & Paul Hermanek Accepted: 7 July 2017 /Published online: 20 July 2017 Springer-Verlag GmbH Germany 2017 Abstract y0 and highest in UICC stage yIV. The 3-year DFS-rate was Purpose Survival is an important indicator of outcome quality always lower (worse) than the 5-year OS rate and higher in rectal carcinoma. The 5-year survival rate is the typical (better) than the 7-year OS rate, with the exception of stage outcome measurement. In patients with neoadjuvant chemo- yIV. radiation followed by curative surgery, 7 years of follow-up is Conclusions Comparisons of survival are only meaningful if recommended. Different methods of survival analysis lead to the same methods are applied. The 3-year rate of DFS was different results. Here, we compared four different methods. always worse than the rate of 5-year OS. Therefore, the 3-year Methods The data of 439 patients with rectal carcinoma treat- rate of DFS appears to be

Journal

International Journal of Colorectal DiseaseSpringer Journals

Published: Jul 20, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off